Table 3.
1-year OS rate | 5-year OS rate | OS | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Young | Old | P | Young | Old | P | Young | Middle-age | Old | P | |
Roviaro, 1985 [2] | NA | 21% | 25% | NS | NA | |||||
Ramalingam, 1998 [4] | NA | 16% | 13% | P<0.001 | NA | |||||
Kuo, 2000 [6] | NA | NA | 9 months | 8 months | 4 months | P<0.0001 | ||||
Radzikowska, 2001 [7] | 33% | 29% | P<0.049 | NA | NR | P=0.01107 | ||||
Mauri, 2006 [8] | NA | NA | 12 months | NA | 11.5 months | P=0.277 | ||||
Subramanian, 2010 [9] | NA | NA | Younger patients had better stage-wise overall and disease-specific survival than older patients | P<0.0001 | ||||||
Inoue, 2014 [10] | NA | 79% | 69% | P<0.001 | NA | |||||
Rich, 2015 [11] | NA | NA | Young patients had a lower overall mortality than older patients (62% vs. 86%, respectively) | P<0.001 |
OS – overall survival; NA – not assessed; NS – not significant; NR – not reported.